However, CEA detection has its limitation, including its relatively low sensitivity and specificity, which make it insufficient for screening large asymptomatic patients alone, and its efficacy for predicting prognosis and monitoring CRC patients remains controversial [10, 11]. This evidence concerns the gene CEACAM5 and colorectal carcinoma.